The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases Publisher

Azizi G^{1, 2} ; Abolhassani H^{2, 3} ; Asgardoon MH² ; Rahnavard J¹ ; Dizaji MZ⁴ ; Yazdani R⁵ ; Mohammadi J^{2, 6} ; Aghamohammadi A²

Show Affiliations

1. Department of Laboratory Medicine, Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran
2. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
3. Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden
4. Department of Medical Genetics, Golestan University of Medical Sciences, Gorgan, Iran
5. Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
6. Department of Biomedical Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Iran

Source: Endocrine, Metabolic and Immune Disorders - Drug Targets Published:2016

Abstract

Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against serious upper and lower respiratory tract infections and pulmonary function improves which leads to an increase in the quality of life of these patients. Successful treatment of PID patients depends on the type of immunodeficiency, regular monitoring of the patient, comorbidities of the patient, and the availability of the products. i¿½ 2016 Bentham Science Publishers.

Related Docs

View other Related Docs

1. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)

2. Autoimmunity in Common Variable Immunodeficiency: Epidemiology, Pathophysiology and Management, Expert Review of Clinical Immunology (2017)

3. Autoimmunity in Primary Antibody Deficiencies, International Archives of Allergy and Immunology (2017)

4. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, Journal of Investigational Allergology and Clinical Immunology (2017)

5. Long-Term Evaluation of a Historical Cohort of Iranian Common Variable Immunodeficiency Patients, Expert Review of Clinical Immunology (2014)

6. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment, Journal of Investigational Allergology and Clinical Immunology (2015)

7. Evaluation of Pulmonary Complications in Patients With Primary Immunodeficiency Disorders, European Annals of Allergy and Clinical Immunology (2017)

8. Clinical Phenotype Classification for Selective Immunoglobulin a Deficiency, Expert Review of Clinical Immunology (2015)

Experts (# of related papers)

View all Related Experts

Tooba Momen (6)

Anahita Babak (1)

Other Related Docs

9. Epidemiology and Pathophysiology of Malignancy in Common Variable Immunodeficiency?, Allergologia et Immunopathologia (2017)

10. T-Cell Abnormalities in Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2016)

11. Frequency and Clinical Manifestations of Patients With Primary Immunodeficiency Disorders in Iran: Update From the Iranian Primary Immunodeficiency Registry, Journal of Clinical Immunology (2006)

12. Selective Iga Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management, Scandinavian Journal of Immunology (2017)

13. Primary Immunodeficiency Disorders in Iran: Update and New Insights From the Third Report of the National Registry, Journal of Clinical Immunology (2014)

14. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort, Journal of Allergy and Clinical Immunology: In Practice (2019)

15. Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis, Journal of Clinical Immunology (2018)

16. Comparison of Bone Mineral Density in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients, Endocrine, Metabolic and Immune Disorders - Drug Targets (2017)

17. A Comparison of Clinical and Immunologic Phenotypes in Familial and Sporadic Forms of Common Variable Immunodeficiency, Scandinavian Journal of Immunology (2017)

18. Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency, Journal of Investigational Allergology and Clinical Immunology (2024)

19. Selective Antibody Deficiency and Its Relation to the Igg2 and Igg3 Subclass Titers in Recurrent Respiratory Infections, Iranian Journal of Immunology (2013)

20. Abnormality of Regulatory T Cells in Common Variable Immunodeficiency, Cellular Immunology (2017)

21. Important Factors Influencing Severity of Common Variable Immunodeficiency, Archives of Iranian Medicine (2016)

22. Primary Immunodeficiency in Iran: First Report of the National Registry of Pid in Children and Adults, Journal of Clinical Immunology (2002)

23. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine, Metabolic and Immune Disorders - Drug Targets (2017)

24. Comparison of the Percentage of Regulatory T Cells and Their P-Stat5 Expression in Allergic and Non-Allergic Common Variable Immunodeficiency Patients, Immunological Investigations (2019)

25. Global Systematic Review of Primary Immunodeficiency Registries, Expert Review of Clinical Immunology (2020)

26. New Therapeutic Approach by Sirolimus for Enteropathy Treatment in Patients With Lrba Deficiency, European Annals of Allergy and Clinical Immunology (2017)

27. Impact of Sars-Cov-2 Pandemic on Patients With Primary Immunodeficiency, Journal of Clinical Immunology (2021)

28. Autoimmunity in Primary T-Cell Immunodeficiencies, Expert Review of Clinical Immunology (2016)

Style	Citing Format
MLA	Azizi G, et al.. "The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases." Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 16, no. 2, 2016, pp. 80-88.
APA	Azizi G, Abolhassani H, Asgardoon MH, Rahnavard J, Dizaji MZ, Yazdani R, Mohammadi J, Aghamohammadi A (2016). The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases. Endocrine, Metabolic and Immune Disorders - Drug Targets, 16(2), 80-88.
Chicago	Azizi G, Abolhassani H, Asgardoon MH, Rahnavard J, Dizaji MZ, Yazdani R, Mohammadi J, Aghamohammadi A. "The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases." Endocrine, Metabolic and Immune Disorders - Drug Targets 16, no. 2 (2016): 80-88.
Harvard	Azizi G et al. (2016) 'The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases', Endocrine, Metabolic and Immune Disorders - Drug Targets, 16(2), pp. 80-88.
Vancouver	Azizi G, Abolhassani H, Asgardoon MH, Rahnavard J, Dizaji MZ, Yazdani R, et al.. The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases. Endocrine, Metabolic and Immune Disorders - Drug Targets. 2016;16(2):80-88.
BibTex	@article{ author = {Azizi G and Abolhassani H and Asgardoon MH and Rahnavard J and Dizaji MZ and Yazdani R and Mohammadi J and Aghamohammadi A}, title = {The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases}, journal = {Endocrine, Metabolic and Immune Disorders - Drug Targets}, volume = {16}, number = {2}, pages = {80-88}, year = {2016} }
RIS	TY - JOUR AU - Azizi G AU - Abolhassani H AU - Asgardoon MH AU - Rahnavard J AU - Dizaji MZ AU - Yazdani R AU - Mohammadi J AU - Aghamohammadi A TI - The Use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases JO - Endocrine, Metabolic and Immune Disorders - Drug Targets VL - 16 IS - 2 SP - 80 EP - 88 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract